drugset / Trial / NCT01848041
Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is an exploratory, proof of concept study to evaluate the safety and efficacy of RVL-1201 dosed once or twice daily for 14 days compared to a placebo (vehicle) control in patients with ptosis.
Timeline
- Start
- 2013-05
- Primary completion
- 2014-01
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | RVL-1201 | Unknown | 0.1 % | Other |